121 related articles for article (PubMed ID: 32529740)
1. Atrase B, a novel metalloprotease with anti-complement and anti-coagulant activity, significantly delays discordant cardiac xenograft rejection.
Fu C; Shi L; Huang X; Feng H; Tan X; Chen S; Zhu L; Sun Q; Chen G
Xenotransplantation; 2020 Sep; 27(5):e12616. PubMed ID: 32529740
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of platelet aggregation and blood coagulation by a P-III class metalloproteinase purified from Naja atra venom.
Sun QY; Wang CE; Li YN; Bao J
Toxicon; 2020 Nov; 187():223-231. PubMed ID: 32971099
[TBL] [Abstract][Full Text] [Related]
3. Purification, cloning and characterization of a metalloproteinase from Naja atra venom.
Sun QY; Bao J
Toxicon; 2010 Dec; 56(8):1459-69. PubMed ID: 20837040
[TBL] [Abstract][Full Text] [Related]
4. Prolongation of cardiac xenograft survival by depletion of complement.
Leventhal JR; Dalmasso AP; Cromwell JW; Platt JL; Manivel CJ; Bolman RM; Matas AJ
Transplantation; 1993 Apr; 55(4):857-65; discussion 865-6. PubMed ID: 8475561
[TBL] [Abstract][Full Text] [Related]
5. Cobra venom P-III class metalloproteinase atrase A induces inflammatory response and cell apoptosis in endothelial cells via its metalloproteinase domain.
Wei Y; Lu QY; Zhong XJ; Guo L; Zeng FY; Sun QY
Toxicon; 2023 Aug; 232():107210. PubMed ID: 37393957
[TBL] [Abstract][Full Text] [Related]
6. Effect of repetitive high-dose treatment with soluble complement receptor type 1 and cobra venom factor on discordant xenograft survival.
Candinas D; Lesnikoski BA; Robson SC; Miyatake T; Scesney SM; Marsh HC; Ryan US; Dalmasso AP; Hancock WW; Bach FH
Transplantation; 1996 Aug; 62(3):336-42. PubMed ID: 8779679
[TBL] [Abstract][Full Text] [Related]
7. Complement inhibition with an anti-C5 monoclonal antibody prevents acute cardiac tissue injury in an ex vivo model of pig-to-human xenotransplantation.
Kroshus TJ; Rollins SA; Dalmasso AP; Elliott EA; Matis LA; Squinto SP; Bolman RM
Transplantation; 1995 Dec; 60(11):1194-202. PubMed ID: 8525509
[TBL] [Abstract][Full Text] [Related]
8. The immunopathology of cardiac xenograft rejection in the guinea pig-to-rat model.
Leventhal JR; Matas AJ; Sun LH; Reif S; Bolman RM; Dalmasso AP; Platt JL
Transplantation; 1993 Jul; 56(1):1-8. PubMed ID: 8333031
[TBL] [Abstract][Full Text] [Related]
9. The effect of xenoreactive antibody and B cell depletion on hyperacute rejection of guinea pig-to-rat cardiac xenografts.
Pruitt SK; Baldwin WM; Barth RN; Sanfilippo F
Transplantation; 1993 Dec; 56(6):1318-24. PubMed ID: 8278996
[TBL] [Abstract][Full Text] [Related]
10. The effect of soluble complement receptor type 1 on hyperacute xenograft rejection.
Pruitt SK; Baldwin WM; Marsh HC; Lin SS; Yeh CG; Bollinger RR
Transplantation; 1991 Nov; 52(5):868-73. PubMed ID: 1949173
[TBL] [Abstract][Full Text] [Related]
11. Effects of leflunomide and deoxyspergualin in the guinea pig-->rat cardiac model of delayed xenograft rejection: suppression of B cell and C-C chemokine responses but not induction of macrophage lectin.
Hancock WW; Miyatake T; Koyamada N; Kut JP; Soares M; Russell ME; Bach FH; Sayegh MH
Transplantation; 1997 Sep; 64(5):696-704. PubMed ID: 9311705
[TBL] [Abstract][Full Text] [Related]
12. Complement-fixing elicited antibodies are a major component in the pathogenesis of xenograft rejection.
Miyatake T; Sato K; Takigami K; Koyamada N; Hancock WW; Bazin H; Latinne D; Bach FH; Soares MP
J Immunol; 1998 Apr; 160(8):4114-23. PubMed ID: 9558123
[TBL] [Abstract][Full Text] [Related]
13. Endothelial cell protection and complement inhibition in xenotransplantation: a novel in vitro model using whole blood.
Banz Y; Cung T; Korchagina EY; Bovin NV; Haeberli A; Rieben R
Xenotransplantation; 2005 Nov; 12(6):434-43. PubMed ID: 16202066
[TBL] [Abstract][Full Text] [Related]
14. The role of CD11b/CD18 mediated neutrophil adhesion in complement deficient xenograft recipients.
Jakobs FM; Davis EA; Qian Z; Liu DY; Baldwin WM; Sanfilippo F
Clin Transplant; 1997 Oct; 11(5 Pt 2):516-21. PubMed ID: 9361953
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of platelet integrin GPIIbIIIa prolongs survival of discordant cardiac xenografts.
Candinas D; Lesnikoski BA; Hancock WW; Otsu I; Koyamada N; Dalmasso AP; Robson SC; Bach FH
Transplantation; 1996 Jul; 62(1):1-5. PubMed ID: 8693522
[TBL] [Abstract][Full Text] [Related]
16. Synergistic suppression of pre-perfusion of donor livers with recipient serum and cobra venom factor treatment on hyperacute rejection following liver xenotransplantation.
Zhu B; Tong C; Guo W; Pu R; Zhang G; Wang L; Li M
Acta Cir Bras; 2012 May; 27(5):301-5. PubMed ID: 22666742
[TBL] [Abstract][Full Text] [Related]
17. A soluble chimeric inhibitor of C3 and C5 convertases, complement activation blocker-2, prolongs graft survival in pig-to-rhesus monkey heart transplantation.
Salerno CT; Kulick DM; Yeh CG; Guzman-Paz M; Higgins PJ; Benson BA; Park SJ; Shumway SJ; Bolman RM; Dalmasso AP
Xenotransplantation; 2002 Mar; 9(2):125-34. PubMed ID: 11897005
[TBL] [Abstract][Full Text] [Related]
18. Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection.
Blakely ML; Van der Werf WJ; Berndt MC; Dalmasso AP; Bach FH; Hancock WW
Transplantation; 1994 Nov; 58(10):1059-66. PubMed ID: 7974711
[TBL] [Abstract][Full Text] [Related]
19. Prolongation of discordant renal xenograft survival by depletion of complement. Comparative effects of systemically administered cobra venom factor and soluble complement receptor type 1 in a guinea-pig to rat model.
Chrupcala M; Pomer S; Staehler G; Waldherr R; Kirschfink C
Transpl Int; 1994; 7 Suppl 1():S650-3. PubMed ID: 11271331
[TBL] [Abstract][Full Text] [Related]
20. Atrase A, a P-III class metalloproteinase purified from cobra venom, exhibits potent anticoagulant activity by inhibiting coagulation pathway and activating the fibrinolytic system.
Zhong XJ; Wang CE; Li YN; Zhang QY; Sun QY
Heliyon; 2024 May; 10(10):e30969. PubMed ID: 38813202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
